Skip to main content

Table 1 Basic population and laboratory data on admission

From: The role of miR1 and miR133a in new-onset atrial fibrillation after acute myocardial infarction

Project

Non-NOAF group (N = 140)

NOAF group

(N = 32)

χ2/t

P

Age (years)

61.18 ± 12.61

65.72 ± 13.01

-1.82

0.07

Males (%)

115 (82.1)

22 (68.8)

2.88

0.09

Diabetes mellitus (%)

37 (26.40)

6 (18.80)

0.82

0.37

Hypertension (%)

75 (53.60)

17 (53.10)

0.002

0.94

WBC (×109/L)

10.8 (7.84–13.32)

10.72 (7.78–14.33)

-0.06

0.95

NEUT%

79.4 (70.23–85.95)

80.95 (68.75–85.63)

-0.3

0.77

Purine trione

386.56 ± 104.52

408.97 ± 109.62

-1.09

0.28

BNP

479 (148.25–1756)

747 (209.08–3346.50)

-1.27

0.2

Cr

73.3 (61.35–91.8)

72.6 (63.18–93.30)

-0.18

0.86

GFR

73.23 ± 21.13

68.57 ± 26.54

1.07

0.29

Mg2+

0.94 (0.89–1.025)

0.94 (0.87–0.10)

-0.48

0.63

 K+

3.76 (3.53–4)

3.79 (3.46–4.24)

-0.32

0.75

The internal diameter of the left atrium

33 (31–36)

37.5 (33–39.75)

-2.9

0.01**

Glasgow prognostic score

0 [Number (%)]

104 (74.30)

16 (50)

6.94a

0.01**a

1 [Number (%)]

34 (24.30)

15 (46.90)

0.01b

0.92b

2 [Number (%)]

2 (1.40)

1 (3.10)

0.98c

0.32c

ESR (Normal: 0–38 mm/h)

Normal [Number (%)]

134 (95.7)

27 (84.4)

5.6

0.02*

Elevated [Number (%)]

6 (4.3)

5 (15.6)

hs-CRP (Normal: 0–5 mg/L)

Normal [Number (%)]

89 (63.6)

16 (50)

2.02

0.16

Elevated [Number (%)]

51 (36.4)

16 (50)

  1. Note: NOAF, new-onset atrial fibrillation; WBC, white blood cell count; NEUT%, percentage of neutrophils; BNP, brain natriuretic peptide; Cr, creatinine; GFR, glomerular filtration rate; Mg2+, magnesium ion; K+ potassium ion; ESR, erythrocyte sedimentation rate; hs-CRP, high-sensitivity C-reactive protein. aGlasgow prognostic score: 0 versus 1; bGlasgow prognostic score: 1 point compared with 2 points; cGlasgow prognostic score: 0 to 2; *P < 0.05; **P < 0.01